Bleo 15k Interactions
There are 270 drugs known to interact with Bleo 15k (bleomycin), along with 3 disease interactions. Of the total drug interactions, 51 are major, 204 are moderate, and 15 are minor.
- View Bleo 15k disease interactions (3)
Medications known to interact with Bleo 15k
Note: Showing generic names only.
- adalimumab
- adenovirus vaccine
- aldesleukin
- alefacept
- alemtuzumab
- allopurinol
- anakinra
- anthrax vaccine adsorbed
- atezolizumab
- avelumab
- azathioprine
- bacitracin
- baricitinib
- bcg
- bcg vaccine
- bendamustine
- bifidobacterium infantis
- bifidobacterium longum
- brentuximab
- brewer's yeast
- busulfan
- cabazitaxel
- canakinumab
- candida albicans extract
- capecitabine
- capreomycin
- carboplatin
- carmustine
- ceftazidime
- cemiplimab
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chlorambucil
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- cholera vaccine, live
- cinoxacin
- ciprofloxacin
- cisplatin
- cladribine
- clofarabine
- clozapine
- coccidioidin skin test
- colistimethate
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- cyclophosphamide
- cytarabine
- cytarabine liposomal
- dacarbazine
- dactinomycin
- daunorubicin
- daunorubicin liposomal
- decitabine
- deferiprone
- delafloxacin
- dengue vaccine
- denosumab
- deucravacitinib
- digoxin
- dimethyl fumarate
- diroximel fumarate
- docetaxel
- dostarlimab
- doxorubicin
- doxorubicin liposomal
- durvalumab
- efalizumab
- efbemalenograstim alfa
- eflapegrastim
- elranatamab
- enoxacin
- epirubicin
- etanercept
- ethotoin
- etoposide
- etrasimod
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydroxyurea
- ibritumomab
- idarubicin
- ifosfamide
- imatinib
- indium pentetreotide in-111
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- interferon alfa-2a
- interferon alfa-2b
- ipilimumab
- isatuximab
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- levofloxacin
- lomefloxacin
- lomustine
- loncastuximab tesirine
- lurbinectedin
- lyme disease vaccine
- measles virus vaccine
- mechlorethamine
- melphalan
- melphalan flufenamide
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mephenytoin
- mercaptopurine
- methotrexate
- mitomycin
- mitoxantrone
- mixed respiratory vaccine
- monomethyl fumarate
- moxifloxacin
- mumps skin test antigen
- mumps virus vaccine
- nadofaragene firadenovec
- nalidixic acid
- natalizumab
- naxitamab
- nelarabine
- niraparib
- nivolumab
- norfloxacin
- paclitaxel
- paclitaxel protein-bound
- palifermin
- pegfilgrastim
- pembrolizumab
- pemetrexed
- pentostatin
- pertussis, acellular
- phenytoin
- plague vaccine
- plazomicin
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- polymyxin b
- ponesimod
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- retifanlimab
- rilonacept
- ritlecitinib
- roflumilast
- ropeginterferon alfa-2b
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- ruxolitinib
- saccharomyces boulardii lyo
- samarium sm 153 lexidronam
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium phosphate p32
- sparfloxacin
- staphage lysate (spl)
- streptococcus salivarius
- streptozocin
- strontium-89 chloride
- tafasitamab
- talimogene laherparepvec
- talquetamab
- tbo-filgrastim
- teclistamab
- telavancin
- temozolomide
- teriflunomide
- tetanus toxoid
- thalidomide
- thioguanine
- thiotepa
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tislelizumab
- tofacitinib
- topotecan
- toripalimab
- trabectedin
- tremelimumab
- treosulfan
- trichophyton skin test
- trovafloxacin
- tuberculin purified protein derivative
- typhoid vaccine, inactivated
- typhoid vaccine, live
Bleo 15k disease interactions
There are 3 disease interactions with Bleo 15k (bleomycin) which include:
More about Bleo 15k (bleomycin)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: antibiotics/antineoplastics
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
Vincristine
Vincristine systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.